Symbol="ACRX"
AssetType="Common Stock"
Name="AcelRx Pharmaceuticals Inc"
Description="AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company is headquartered in Redwood City, California."
CIK="1427925"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="351 GALVESTON DRIVE, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="18627700"
EBITDA="-29335000"
PERatio="None"
PEGRatio="0"
BookValue="0.948"
DividendPerShare="0"
DividendYield="0"
EPS="-3.39"
RevenuePerShareTTM="0.22"
ProfitMargin="0"
OperatingMarginTTM="-15.31"
ReturnOnAssetsTTM="-0.524"
ReturnOnEquityTTM="-1.216"
RevenueTTM="2024000"
GrossProfitTTM="-5030000"
DilutedEPSTTM="-3.39"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.556"
AnalystTargetPrice="8"
TrailingPE="-"
ForwardPE="1.06"
PriceToSalesRatioTTM="11.8"
PriceToBookRatio="0.69"
EVToRevenue="10.28"
EVToEBITDA="0.309"
Beta="0.256"
num_52WeekHigh="6.2"
num_52WeekLow="0.55"
num_50DayMovingAverage="1.059"
num_200DayMovingAverage="1.378"
SharesOutstanding="16340100"
DividendDate="None"
ExDividendDate="None"
symbol="ACRX"
open="1.13"
high="1.23"
low="1.06"
price="1.14"
volume="277897.00"
latest_trading_day="2023-08-24"
previous_close="1.12"
change="0.02"
change_percent="1.7857%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="49"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="175944"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.18"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="519"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0086.jpeg"
image_negative_thumbnail_id_2="512"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0093.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="672"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_positive_thumbnail_id_2="670"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0038.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
